Renal Cancer - Results from #4420

Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis June 13, 2018

The association of renal cell carcinoma with gastrointestinal stromal tumors June 12, 2018

Basic Parameters of Blood Count, Serum Sodium, and Creatinine as Prognostic Factors for Renal Cell Carcinoma at Five-Year Follow-Up June 11, 2018

An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors June 11, 2018

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group June 7, 2018

Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum June 6, 2018

A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model June 6, 2018

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma June 5, 2018

Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies June 4, 2018

Validation of the 16-Gene Recurrence Score in patients with locoregional, high-risk renal cell carcinoma from a phase 3 trial of adjuvant sunitinib June 4, 2018

What is the hospital volume threshold to optimize inpatient complication rate after partial nephrectomy? June 4, 2018

Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial June 1, 2018

Partial Nephrectomy in Central Renal Tumors June 1, 2018

Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma May 31, 2018

The Role of DNA Methylation in Renal Cell Carcinoma May 31, 2018

Updates to the Management of Kidney Cancer May 30, 2018

Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis May 30, 2018

Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma May 29, 2018

Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor models May 29, 2018

[Roles and molecular mechanisms of hypoxia-inducible factors in renal cell carcinoma] May 29, 2018

Page 222 of 456